These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 37534900)

  • 21. SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.
    Bashor L; Gagne RB; Bosco-Lauth AM; Bowen RA; Stenglein M; VandeWoude S
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing.
    Pereira F
    J Immunol Methods; 2021 Jan; 488():112906. PubMed ID: 33137303
    [No Abstract]   [Full Text] [Related]  

  • 23. RNA interference as a promising treatment against SARS-CoV-2.
    Donia A; Bokhari H
    Int Microbiol; 2021 Jan; 24(1):123-124. PubMed ID: 32875426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    Wang X; Wang W; Wang T; Wang J; Jiang Y; Wang X; Qiu Z; Feng N; Sun W; Li C; Yang S; Xia X; He H; Gao Y
    J Virol; 2023 Mar; 97(3):e0001123. PubMed ID: 36877072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome Coronavirus 2 ORF8 Protein Inhibits Type I Interferon Production by Targeting HSP90B1 Signaling.
    Chen J; Lu Z; Yang X; Zhou Y; Gao J; Zhang S; Huang S; Cai J; Yu J; Zhao W; Zhang B
    Front Cell Infect Microbiol; 2022; 12():899546. PubMed ID: 35677655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.
    Kim D; Kim S; Park J; Chang HR; Chang J; Ahn J; Park H; Park J; Son N; Kang G; Kim J; Kim K; Park MS; Kim YK; Baek D
    Nat Commun; 2021 Aug; 12(1):5120. PubMed ID: 34433827
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Cheng Y; Peng X
    Phys Chem Chem Phys; 2022 Jul; 24(27):16876-16883. PubMed ID: 35788229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection.
    Lin X; Fu B; Xiong Y; Xing N; Xue W; Guo D; Zaky M; Pavani K; Kunec D; Trimpert J; Wu H
    PLoS Pathog; 2023 Jan; 19(1):e1011128. PubMed ID: 36689483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique view of SARS-CoV-2 through the lens of ORF8 protein.
    Hassan SS; Aljabali AAA; Panda PK; Ghosh S; Attrish D; Choudhury PP; Seyran M; Pizzol D; Adadi P; Abd El-Aziz TM; Soares A; Kandimalla R; Lundstrom K; Lal A; Azad GK; Uversky VN; Sherchan SP; Baetas-da-Cruz W; Uhal BD; Rezaei N; Chauhan G; Barh D; Redwan EM; Dayhoff GW; Bazan NG; Serrano-Aroca Á; El-Demerdash A; Mishra YK; Palu G; Takayama K; Brufsky AM; Tambuwala MM
    Comput Biol Med; 2021 Jun; 133():104380. PubMed ID: 33872970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
    Ghorbani A; Samarfard S; Ramezani A; Izadpanah K; Afsharifar A; Eskandari MH; Karbanowicz TP; Peters JR
    Infect Genet Evol; 2020 Nov; 85():104556. PubMed ID: 32937193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure.
    Ahmadpour D; Ahmadpoor P
    Iran J Kidney Dis; 2020 May; 14(3):167-172. PubMed ID: 32361692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A SARS-CoV-2 -human metalloproteome interaction map.
    Chasapis CT; Georgiopoulou AK; Perlepes SP; Bjørklund G; Peana M
    J Inorg Biochem; 2021 Jun; 219():111423. PubMed ID: 33813307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ORF8a as a viroporin in SARS-CoV-2 infection?
    Zandi M
    Cytokine Growth Factor Rev; 2021 Oct; 61():1. PubMed ID: 34362671
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling.
    López-Ayllón BD; de Lucas-Rius A; Mendoza-García L; García-García T; Fernández-Rodríguez R; Suárez-Cárdenas JM; Santos FM; Corrales F; Redondo N; Pedrucci F; Zaldívar-López S; Jiménez-Marín Á; Garrido JJ; Montoya M
    Front Immunol; 2023; 14():1220306. PubMed ID: 37545510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types.
    Miserey-Lenkei S; Trajkovic K; D'Ambrosio JM; Patel AJ; Čopič A; Mathur P; Schauer K; Goud B; Albanèse V; Gautier R; Subra M; Kovacs D; Barelli H; Antonny B
    Biol Cell; 2021 Jul; 113(7):311-328. PubMed ID: 33666950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism.
    Jin X; Sun X; Chai Y; Bai Y; Li Y; Hao T; Qi J; Song H; Wong CCL; Gao GF
    Sci China Life Sci; 2023 Jan; 66(1):152-164. PubMed ID: 36184694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations.
    Wierbowski SD; Liang S; Liu Y; Chen Y; Gupta S; Andre NM; Lipkin SM; Whittaker GR; Yu H
    Nat Methods; 2021 Dec; 18(12):1477-1488. PubMed ID: 34845387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.